HCST and osteosarcoma: The first NK-cell-based CAR were NKG2D-expressing CAR-NK cells containing a NKG2D–DNAX activation protein 10 (DAP10)–CD3ζ construct, which have shown encouraging results in vitro and in a mouse model of osteosarcoma (87).